Rose Geoffrey Beran
Chief Commercial Officer
Rose Geoffrey Beran has filed 5 SEC Form 4 filings (21 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Rose Geoffrey Beran is listed as Chief Commercial Officer at Pulmonx Corp. Inside the rolling window, Rose Geoffrey Beran reported no open-market purchases and 4 open-market sales totaling $51K in LUNG. The largest disclosed transaction in the window is a sale of 7,879 LUNG shares on Sep 1, 2026, worth $18K.
Companies traded
Other insiders at LUNG
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$51K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 2, 2025 | LUNG | Sale | $4K |
| Sep 2, 2025 | LUNG | Sale | $3K |
| Sep 2, 2025 | LUNG | Sale | $3K |
| Sep 2, 2025 | LUNG | Sale | $1K |
Frequently asked questions
How many SEC Form 4 filings has Rose Geoffrey Beran made?
Rose Geoffrey Beran has filed 5 SEC Form 4 filings (21 transaction rows) across 1 company since 2025.
Which companies does Rose Geoffrey Beran trade?
Rose Geoffrey Beran has filed SEC Form 4 disclosures for 1 company, including LUNG.
When was Rose Geoffrey Beran's most recent SEC Form 4 filing?
Rose Geoffrey Beran's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Rose Geoffrey Beran's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rose Geoffrey Beran is listed as Chief Commercial Officer.
What is Rose Geoffrey Beran's total buy and sell value in the current window?
Inside the rolling retention window, Rose Geoffrey Beran bought $0 and sold $51K based on SEC Form 4 filings.
What was Rose Geoffrey Beran's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,879 LUNG shares on 2026-09-01, worth $18K, per SEC Form 4 filings.